Brilliant Minds

Board of Directors.

Our board of directors serve as a catalyst for contract development and manufacturing, continuous flow and other advanced manufacturing technologies, policy and regulatory science, cyber security, and more. As proven experts in their fields, Phlow’s board members have a diverse range of experiences ranging from increasing access to lifesaving medications for HIV/AIDS, malaria, tuberculosis and other diseases around the world to lowering the cost of high-cost generic medicines at the pharmacy counter here at home.
Eric Edwards, M.D., Ph.D.

CO-FOUNDER & CEO

Dr. Frank Gupton, Ph.D.

CO-FOUNDER, PHLOW™
CEO, MEDICINES FOR ALL

Marshall L. Summar, M.D.

STRATEGIC ADVISOR AND MEMBER OF THE BOARD

Rosemary Gibson

STRATEGIC ADVISOR AND MEMBER OF THE BOARD

Thomas O’Malley

STRATEGIC ADVISOR AND MEMBER OF THE BOARD

Melinda S. Hancock

STRATEGIC ADVISOR AND MEMBER OF THE BOARD

Business Advisory Board.

Salvatore Guccione

MANAGING DIRECTOR AT
VASTO ADVISORS

Steven Klosk

FORMER CEO OF CAMBREX

Tim M. Mayleben

PRESIDENT OF TWO PRIVATE BIOPHARMA COMPANIES + BOARD MEMBER OF MARINUS PHARMA AND LANDOS BIOPHARMA

Joe Smith

CHIEF SCIENTIFIC OFFICER AT BD

Guy Villax

FORMER CEO AT HOVIONE

Joseph Warchol

CHIEF FINANCIAL OFFICER NORTH AMERICA AT CURIUM PHARMA

Executive Leadership.

Phlow’s team has unmatched experience in research, development, and commercialization of API, pharmaceuticals, and medical device products. In addition to having a deep understanding of the challenges associated with building complex products using new technology and advanced manufacturing facilities, we also recognize that quality, efficiency, and affordability of medicines is paramount to a stable healthcare system.
Eric Edwards, M.D., Ph.D.

CO-FOUNDER & CEO

Elizabeth Whalley Buono, J.D.

CHIEF LEGAL AND COMPLIANCE OFFICER

Dan Hackman

PRESIDENT

Dave Ryan

CHIEF FINANCIAL OFFICER

Karen A. Watson, MSA, PCC

CHIEF HUMAN RESOURCE OFFICER

Senior Leadership.

Our senior leadership team has made Phlow one of the leading contract development and manufacturing organizations in the nation. Phlow’s team of trailblazers are committed to optimizing active pharmaceutical ingredient and finished dosage form production to enhance the security of medicine supply chains.
Andrew Carpenter

EVP OF MANUFACTURING, SCIENCE, & TECHNOLOGY

Robby Demeria

CHIEF CORPORATE AFFAIRS OFFICER

Valerie Jewett

VICE PRESIDENT OF GOVERNMENT RELATIONS

Wayne Motsek

EVP OF QUALITY

Christopher Rogers

EVP OF COMMERCIAL INITIATIVES

Juan Piacquadio

VICE PRESIDENT OF INFORMATION SERVICES, CIO

Bill Seaton

EVP OF OPERATIONS AND ENGINEERING

Patricia Watson

EVP OF REGULATORY AFFAIRS